Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Talinolol
Cat. No.:
0225LY-1202
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
(+/-)-Talinolol functions as a selective beta-1 adrenoceptor antagonist widely recognized for its antihypertensive properties and cardioprotective effects.
Synonym:
57460-41-0; Cordanum; Racemic talinolol; (+-)-Talinolol; Talinololum; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; TALINOLOL [WHO-DD]; 1-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-3-cyclohexylurea; (+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea; (+-)-1-(4-(3-(tert-Butylamino)-2-hydroxypropoxy)phenyl)-3-cyclohexylharnstoff; Urea, N-cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-, (+-)-
CAS No.:
57460-41-0
Compound CID:
68770
Formula:
C20H33N3O3
Formula Weight:
363.49
Specification
Relative Density:
1.11 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Talinolol can be used in cardiovascular pharmacology to study the selective blockade of beta-1 adrenoceptors and its impact on heart rate regulation.
Library Information
Target:
β1-Adrenergic receptor
Receptor:
GPCR
Pathways:
Neuronal signaling; GPCR/G protein signaling
Plate Number:
AOCL-16
Plate Location:
d9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
100 mg/mL; 275.11 mM





